| dc.contributor.author | Steele, L | en_US |
| dc.contributor.author | Stuart, B | en_US |
| dc.contributor.author | Axon, E | en_US |
| dc.contributor.author | Lax, SJ | en_US |
| dc.contributor.author | Harvey, J | en_US |
| dc.contributor.author | Roberts, A | en_US |
| dc.contributor.author | Santer, M | en_US |
| dc.contributor.author | Williams, HC | en_US |
| dc.contributor.author | Drucker, AM | en_US |
| dc.contributor.author | Boyle, RJ | en_US |
| dc.date.accessioned | 2023-01-10T14:59:37Z | |
| dc.date.issued | 2022-07-28 | en_US |
| dc.identifier.issn | 1465-1858 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/83634 | |
| dc.description.abstract | Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To compare the efficacy and safety of topical anti-inflammatory treatments for reducing eczema symptoms or signs or improving eczema-related quality of life in children and adults with eczema, by undertaking a network meta-analysis. To provide a clinically useful ranking of these treatments according to their efficacy and safety. | en_US |
| dc.relation.ispartof | Cochrane Database of Systematic Reviews | en_US |
| dc.title | Topical anti-inflammatory treatments for eczema: network meta-analysis | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1002/14651858.CD015064 | en_US |
| pubs.issue | 7 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 2022 | en_US |
